Cargando…

Development of Spheroid-FPOP: An In-Cell Protein Footprinting Method for 3D Tumor Spheroids

[Image: see text] Many cancer drugs fail at treating solid epithelial tumors with hypoxia and insufficient drug penetration thought to be contributing factors to the observed chemoresistance. Owing to this, it is imperative to evaluate potential cancer drugs in conditions as close to in vivo as poss...

Descripción completa

Detalles Bibliográficos
Autores principales: Shortt, Raquel L., Wang, Yijia, Hummon, Amanda B., Jones, Lisa M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983004/
https://www.ncbi.nlm.nih.gov/pubmed/36700916
http://dx.doi.org/10.1021/jasms.2c00307
_version_ 1784900453345001472
author Shortt, Raquel L.
Wang, Yijia
Hummon, Amanda B.
Jones, Lisa M.
author_facet Shortt, Raquel L.
Wang, Yijia
Hummon, Amanda B.
Jones, Lisa M.
author_sort Shortt, Raquel L.
collection PubMed
description [Image: see text] Many cancer drugs fail at treating solid epithelial tumors with hypoxia and insufficient drug penetration thought to be contributing factors to the observed chemoresistance. Owing to this, it is imperative to evaluate potential cancer drugs in conditions as close to in vivo as possible, which is not always done. To address this, we developed a mass spectrometry-based protein footprinting method for exploring the impact of hypoxia on protein in 3D colorectal cancer cells. Our group has previously extended the protein footprinting method fast photochemical oxidation of proteins (FPOP) for live cell analysis (IC-FPOP); however, this is the first application of IC-FPOP in a 3D cancer model. In this study, we perform IC-FPOP on intact spheroids (Spheroid-FPOP) using a modified version of the static platform incubator with an XY movable stage (PIXY) FPOP platform. We detected modification in each of three spheroid layers, even the hypoxic core. Pathway analysis revealed protein modifications in over 10 distinct protein pathways, including some involved in protein ubiquitination; a process modulated in cancer pathologies. These results demonstrate the feasibility of Spheroid-FPOP to be utilized as a tool to interrogate protein interactions within a native tumor microenvironment.
format Online
Article
Text
id pubmed-9983004
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-99830042023-03-04 Development of Spheroid-FPOP: An In-Cell Protein Footprinting Method for 3D Tumor Spheroids Shortt, Raquel L. Wang, Yijia Hummon, Amanda B. Jones, Lisa M. J Am Soc Mass Spectrom [Image: see text] Many cancer drugs fail at treating solid epithelial tumors with hypoxia and insufficient drug penetration thought to be contributing factors to the observed chemoresistance. Owing to this, it is imperative to evaluate potential cancer drugs in conditions as close to in vivo as possible, which is not always done. To address this, we developed a mass spectrometry-based protein footprinting method for exploring the impact of hypoxia on protein in 3D colorectal cancer cells. Our group has previously extended the protein footprinting method fast photochemical oxidation of proteins (FPOP) for live cell analysis (IC-FPOP); however, this is the first application of IC-FPOP in a 3D cancer model. In this study, we perform IC-FPOP on intact spheroids (Spheroid-FPOP) using a modified version of the static platform incubator with an XY movable stage (PIXY) FPOP platform. We detected modification in each of three spheroid layers, even the hypoxic core. Pathway analysis revealed protein modifications in over 10 distinct protein pathways, including some involved in protein ubiquitination; a process modulated in cancer pathologies. These results demonstrate the feasibility of Spheroid-FPOP to be utilized as a tool to interrogate protein interactions within a native tumor microenvironment. American Chemical Society 2023-01-26 /pmc/articles/PMC9983004/ /pubmed/36700916 http://dx.doi.org/10.1021/jasms.2c00307 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Shortt, Raquel L.
Wang, Yijia
Hummon, Amanda B.
Jones, Lisa M.
Development of Spheroid-FPOP: An In-Cell Protein Footprinting Method for 3D Tumor Spheroids
title Development of Spheroid-FPOP: An In-Cell Protein Footprinting Method for 3D Tumor Spheroids
title_full Development of Spheroid-FPOP: An In-Cell Protein Footprinting Method for 3D Tumor Spheroids
title_fullStr Development of Spheroid-FPOP: An In-Cell Protein Footprinting Method for 3D Tumor Spheroids
title_full_unstemmed Development of Spheroid-FPOP: An In-Cell Protein Footprinting Method for 3D Tumor Spheroids
title_short Development of Spheroid-FPOP: An In-Cell Protein Footprinting Method for 3D Tumor Spheroids
title_sort development of spheroid-fpop: an in-cell protein footprinting method for 3d tumor spheroids
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983004/
https://www.ncbi.nlm.nih.gov/pubmed/36700916
http://dx.doi.org/10.1021/jasms.2c00307
work_keys_str_mv AT shorttraquell developmentofspheroidfpopanincellproteinfootprintingmethodfor3dtumorspheroids
AT wangyijia developmentofspheroidfpopanincellproteinfootprintingmethodfor3dtumorspheroids
AT hummonamandab developmentofspheroidfpopanincellproteinfootprintingmethodfor3dtumorspheroids
AT joneslisam developmentofspheroidfpopanincellproteinfootprintingmethodfor3dtumorspheroids